Third Rock Ventures III, L.P. - 10%+ Owner at Nurix Therapeutics, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
NRIX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Third Rock Ventures III, L.P. since 10 Sep 2025

Reported holdings for Third Rock Ventures III, L.P. in Nurix Therapeutics, Inc.

Form 4 holding 10%+ Owner

Nurix Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,422,549
Estimated value
$34,236,100
Report date
06 May 2021
Price
$10.00
Ownership
Direct
Form 4 holding 10%+ Owner

Nurix Therapeutics, Inc.

Security class
Common Stock
Shares / value
86,799
Estimated value
$868,259
Report date
06 May 2021
Price
$10.00
Ownership
Indirect

Transaction history for Third Rock Ventures III, L.P. in Nurix Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .